Screener
enGene Therapeutics Inc. ENGN Q2 2026 earnings
Reported June 15, 2026 · Before market open
EPS-$0.43Beat by $0.05
EPS estimate-$0.48
Next report
Date not yet announcedVersus estimates
Diluted EPS
FAQ
- When did enGene Therapeutics Inc. report Q2 2026 earnings?
- enGene Therapeutics Inc. (ENGN) reported Q2 2026 earnings on June 15, 2026 before market open.
- What were enGene Therapeutics Inc.'s Q2 2026 revenue and EPS?
- enGene Therapeutics Inc. reported eps of $-0.43 for Q2 2026.
- Did enGene Therapeutics Inc. beat estimates in Q2 2026?
- EPS beat the consensus estimate of $-0.48 by $0.05.
- How did enGene Therapeutics Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 15.7% from $-0.51.
- Where can I find enGene Therapeutics Inc.'s Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-270384) and the 10-Q periodic report (0001193125-26-270386) directly on SEC EDGAR. The filing index links above go to sec.gov.
